Skip to main
GRAL
GRAL logo

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has demonstrated significant stock appreciation of nearly 90% in the last month, reflecting growing investor confidence stemming from favorable PATHFINDER 2 ESMO data and a bullish outlook on the NHS Galleri trial. The company's comprehensive Total Addressable Market (TAM) analysis reveals substantial revenue opportunities, estimated at approximately $3.7 billion in the UK by 2026, with potential growth to $4.0 billion by 2035. Additionally, GRAIL's strategic partnerships aim to enhance access to these markets, positioning the company favorably within the multi-cancer early detection sector despite lingering uncertainties around regulatory approvals and Medicare reimbursement.

Bears say

GRAIL Inc has consistently reported significant net losses since its inception and anticipates ongoing losses due to the costs associated with studies, regulatory approvals, and infrastructure expansion. The company faces multiple challenges, including potential delays in Congressional action for CMS reimbursement, adoption difficulties for its innovative multi-cancer early detection test, and competitive pressures from larger diagnostics firms with established infrastructures. Additionally, uncertainties regarding financing and regulatory timelines, coupled with high selling, general, and administrative expenses, may hinder GRAIL's ability to effectively commercialize its products and achieve financial stability.

GRAIL Inc (GRAL) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 3 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Nov 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.